Roger Sawhney - 01 Oct 2026 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Reporting relationship: Director
Issuer ticker: ABUS
Reported as of: 01 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2026, 16:09:53 UTC
Prior SEC filing: 23 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney

Key filing fact

Roger Sawhney filed Form 4 for Arbutus Biopharma Corp (ABUS) on 07 Oct 2026.

Key facts

This page summarizes Roger Sawhney's Form 4 filing for Arbutus Biopharma Corp (ABUS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Oct 2026, 16:09.

Change

Previous filing in this sequence was filed on 23 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001858748 Primary reporting owner

Sawhney Roger

Relationship: Director
Address: C/O ARBUTUS BIOPHARMA CORPORATION, 701 VETERANS CIRCLE, WARMINSTER
Signature: /s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney
Signature date: 07 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABUS transaction

Common Shares

Disposed to Issuer

Transaction value
Shares: -17,142
Change %: -56%
Price: $5.00^*
Shares after: 13,683
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.